enGene Holdings Inc (ENGN) Net Assets per Single Share
This daily price chart for enGene Holdings Inc. (ENGN) is subject to the impact of production scaling complexities and FDA inspections, with the metric currently at 3.43. The business is based on the implementation of a non-viral gene delivery method to combat bladder tumors. The company's growth relies on the uniqueness of its technological platform and the potential for collaboration with major medical behemoths.
Summary analytical data breakdowns for engene.com (ENGN)
- stock price and consensus target price:
- market capitalization details:
- shareholders' equity book value data:
- debt burden and liquidity indicators:
Total Debt to Capital enGene Holdings Inc.|ENGN - Long-Term Debt to Capital|Short-Term Debt to Equity enGene|ENGN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio enGene Holdings Inc.|ENGN - Company Long-Term Liabilities|Company Short-Term Debts enGene|Quick Liquidity Indicator engene.com
- earnings and multiples data:
General company analysis:ENGN - enGene Bio
For enGene Holdings Inc. (ENGN), whose valuation is based on gene therapy patents, the book value per share determines the residual capital of the business after all liabilities are settled. This metric measures the actual value of net assets, allowing an investor to identify fundamental support levels and assess the risk of overpaying for the security through the visualization of the book value per share.
Competitor analysis
Argenx - Book Value per Share|Book Value of One Share BioNTech Pharma (BNTX)|Abivax Corp (ABVX) - Net Assets per Single Share|Equity per Share ADMA|Net Assets per Single Share Protagonist|Immunovant Inc - Share Book Value|Book Value per Share KNSA|GRFS (Grifols Biemat) - Accounting Value of a Share|Book Value per Share ADPT (Adaptive Biotechnologies)|Book Value per Share celldex.com CLDX|AUPH - Net Assets per Single Share|Accounting Value of a Share BCRX (BioCryst Pharmaceuticals, Inc.)|Vera Pharma (VERA) - Net Assets per Single Share|Accounting Value per Share Dianthus Corp|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp|Accounting Value per Share TRML (Tourmaline Bio)|PGEN (Precigen Inc) - Accounting Value of a Share|Book Value per Share PHAR (Pharming)|Net Assets per Share Nektar Corp (NKTR)|UPB - Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|Immunome (IMNM) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|Accounting Value per Share KALV|Book Value per Share Septerna Pharma|Net Assets per Single Share Pieris Pharmaceuticals (PVLA)|savarapharma.com - Equity per Share|Book Value per Share RIGL (Rigel Pharmaceuticals, Inc.)|AnaptysBio Inc (ANAB) - Net Asset Value per Share|Astria Pharma - Book Value per Share|Net Asset Value per Share RAPT Therapeutics Inc.|aerovatetx.com (JBIO) - Net Assets per Single Share|Equity per Share ACRS|KYTX (Kyverna Therapeutics, Inc.) - Book Value per Share|TLSA - Book Value of One Share|Book Value per Share CABA|VTYX - Net Asset Value per Share|Net Assets per Single Share Theratechnologies Inc. THTX|AVTX: Equity per Share|Eledon Pharmaceuticals, Inc. - Book Value per Share|Net Asset Value per Share Agenus, Inc.|CLYM (Climb Bio, Inc.) - Accounting Value per Share|Zura Bio Ltd - Accounting Value of a Share|ATYR (aTyr Pharma, Inc.) - Book Value per Share|ADAG: Accounting Value of a Share|Net Assets per Single Share ImageneBio Inc (IMA)|STTK - Net Asset Value per Share|Net Assets per Single Share Equillium EQ|Connect Biopharma Holdings - Net Assets per Single Share|Immunic Inc - Book Value per Share|ATRA (Atara Biotherapeutics) - Equity per Share|IFRX: Book Value per Share|XFOR - Net Assets per Share|Net Assets per Single Share Adicet Bio Inc.|Equity per Share CELU (Celularity Corp)|Book Value per Share INMB|barinthusbio.com (BRNS) - Book Value of One Share|Net Assets per Single Share Kezar Life Sciences, Inc. KZR|Net Assets per Share SAB Biotherapeutics Inc. (SABS)|AKTX: Accounting Value per Share|Accounting Value of a Share ENLV (Enlivex Therapeutics)|QTTB: Book Value per Share|GOVX - Net Assets per Share|Net Assets per Single Share Edesa Biotech|Equity per Share IBIO (iBio Inc)|Book Value per Share CARM|Accounting Value per Share XTL Bio XTLB|Bolt Biotherapeutics, Inc. - Accounting Value per Share|Net Assets per Share HCW Biologics, Inc. (HCWB)|Aptevo - Book Value per Share|Net Asset Value per Share AIM ImmunoTech, Inc.|aditxt.com (ADTX) - Net Assets per Single Share|Equity per Share GRI|XRTX (XORTX Therapeutics Inc.) - Book Value per Share|HIND - Book Value of One Share|Net Assets per Single Share Revelation Biosciences, Inc. (REVB)|Indaptus Therapeutics Inc - Equity per Share|Net Assets per Single Share Scinai SCNI|CALI (CalciMedica Inc) - Share Book Value|Affimed Therapeutics - Book Value per Share|Accounting Value of a Share ALLK (Allakos Inc.)|HOOK: Book Value per Share|IGM Biosciences (IGMS) - Book Value per Share|Net Assets per Single Share iTeos|OCEA: Accounting Value of a Share|Net Assets per Single Share TC Biopharm (TCBP)|Accounting Value per Share thirdharmonicbio.com THRD